HomeRGC ⢠NASDAQ
Regencell Bioscience Holdings Ltd
add
Market news
HVT
1.18%
Financials
Income Statement
Revenue
Net Income
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | ā | ā |
Operating expense | 1.21M | -14.74% |
Net income | -1.12M | 15.45% |
Net profit margin | ā | ā |
Earnings per share | ā | ā |
EBITDA | -1.14M | 15.78% |
Effective tax rate | ā | ā |
Balance Sheet
Total Assets
Total Liabilities
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 7.96M | -31.16% |
Total assets | 8.44M | -33.15% |
Total liabilities | 219.51K | -65.28% |
Total equity | 8.22M | ā |
Shares outstanding | 13.01M | ā |
Price to book | 45.71 | ā |
Return on assets | -35.92% | ā |
Return on capital | -36.50% | ā |
Cash Flow
Net Change in Cash
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -1.12M | 15.45% |
Cash from operations | ā | ā |
Cash from investing | ā | ā |
Cash from financing | ā | ā |
Net change in cash | ā | ā |
Free cash flow | ā | ā |
Previous close
$28.80
Day range
$28.63 - $30.60
Year range
$3.03 - $69.00
Market cap
396.76M USD
Avg Volume
1.37M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
About
Founded
2014
Website
Employees
12